Assessment of The Efficacy of The Two-Year Treatment With Omalizumab, According to The Pediatric Registry of The Children with Severe Persistent Uncontrolled Asthma
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1511
https://www.valueinhealthjournal.com/article/S1098-3015(17)31845-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1362
First Page :
A649
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31845-4&doi=10.1016/j.jval.2017.08.1511